The High Commission of India in Dhaka hosted a special program on Tuesday with the participation of a broad number of pharmaceutical brands operating in Bangladesh. -AA
The High Commission of India (HCI) in Dhaka hosted "PharmaConnect" on 18th November 2025, a networking and knowledge-sharing event bringing together senior leaders from top Bangladeshi pharmaceutical companies. The event preceded the upcoming participation of Bangladeshi pharmaceutical companies at CPHI-PMEC India 2025, one of the world's largest pharmaceutical exhibitions. "PharmaConnect" highlighted the longstanding complementarities between India and Bangladesh in the pharmaceutical sector.
The event showcased how India's globally competitive pharmaceutical industry and Bangladesh's fast-growing manufacturing capabilities can work together to strengthen supply chains, access new technologies, and deepen commercial linkages. Indian High Commissioner to Bangladesh Pranay Verma underscored the strategic necessity of the pharmaceutical sector in the economic partnership between India and Bangladesh. He noted that India remains a trusted and reliable partner for Bangladesh-especially in API sourcing, process technologies, and pharmaceutical machinery-and emphasized that greater reciprocal assistance in this sector will not only boost industrial growth but also support affordable and accessible healthcare for millions of people across the region.
Pranay Verma expressed confidence that "PharmaConnect" will help build new business linkages and enhance India-Bangladesh engagement in a future-oriented, innovation-driven framework. Many Bangladeshi companies will be participating in CPHI-PMEC India 2025, scheduled from 25th to 27th November, which is recognized as one of the largest industry platforms connecting global manufacturers, innovators, investors and policymakers.
Latest News